DE947222T1 - Verfahren zur Aktivierung von photoempfindlichen Mitteln - Google Patents

Verfahren zur Aktivierung von photoempfindlichen Mitteln

Info

Publication number
DE947222T1
DE947222T1 DE0947222T DE99201064T DE947222T1 DE 947222 T1 DE947222 T1 DE 947222T1 DE 0947222 T DE0947222 T DE 0947222T DE 99201064 T DE99201064 T DE 99201064T DE 947222 T1 DE947222 T1 DE 947222T1
Authority
DE
Germany
Prior art keywords
less
photosensitizing agent
photosensitive agents
usual
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE0947222T
Other languages
English (en)
Inventor
Anna M Richter
Julia G Levy
Elizabeth Waterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of British Columbia
Original Assignee
University of British Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of British Columbia filed Critical University of British Columbia
Publication of DE947222T1 publication Critical patent/DE947222T1/de
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Radiology & Medical Imaging (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Adhesives Or Adhesive Processes (AREA)
DE0947222T 1992-11-20 1993-11-17 Verfahren zur Aktivierung von photoempfindlichen Mitteln Pending DE947222T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97954692A 1992-11-20 1992-11-20

Publications (1)

Publication Number Publication Date
DE947222T1 true DE947222T1 (de) 2000-05-04

Family

ID=25526957

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69327972T Expired - Lifetime DE69327972T2 (de) 1992-11-20 1993-11-17 Aktivierung von photoempfindlichen mitteln
DE69334009T Expired - Lifetime DE69334009T2 (de) 1992-11-20 1993-11-17 Verfahren zur Aktivierung von photoempfindlichen Mitteln
DE0947222T Pending DE947222T1 (de) 1992-11-20 1993-11-17 Verfahren zur Aktivierung von photoempfindlichen Mitteln

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69327972T Expired - Lifetime DE69327972T2 (de) 1992-11-20 1993-11-17 Aktivierung von photoempfindlichen mitteln
DE69334009T Expired - Lifetime DE69334009T2 (de) 1992-11-20 1993-11-17 Verfahren zur Aktivierung von photoempfindlichen Mitteln

Country Status (21)

Country Link
US (2) US5705518A (de)
EP (2) EP0680365B1 (de)
JP (1) JP3146008B2 (de)
KR (1) KR100230588B1 (de)
AT (2) ATE189966T1 (de)
AU (1) AU679016B2 (de)
CA (1) CA2149636C (de)
DE (3) DE69327972T2 (de)
DK (2) DK0947222T3 (de)
ES (2) ES2148132T3 (de)
FI (1) FI952436A (de)
GR (1) GR3033362T3 (de)
HK (1) HK1025059A1 (de)
HU (1) HU224722B1 (de)
IL (1) IL107676A (de)
NO (1) NO323107B1 (de)
PH (1) PH31688A (de)
PL (1) PL172480B1 (de)
PT (2) PT947222E (de)
WO (1) WO1994012239A1 (de)
ZA (1) ZA938710B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020058008A1 (en) * 1989-07-28 2002-05-16 Kennedy James C. Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6710066B2 (en) * 1989-07-28 2004-03-23 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US20040110819A1 (en) * 1991-10-28 2004-06-10 Queen's University At Kingston Photochemotherapeutic method using 5-aminolevulinic acid and other precursors of endogenous porphyrins
US6890555B1 (en) * 1992-02-05 2005-05-10 Qlt, Inc. Liposome compositions of porphyrin photosensitizers
US5368841A (en) * 1993-02-11 1994-11-29 The General Hospital Corporation Photodynamic therapy for the destruction of the synovium in the treatment of rheumatoid arthritis and the inflammatory arthritides
JP3565442B2 (ja) * 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および/または治療剤
US5798349A (en) 1994-03-14 1998-08-25 The General Hospital Corporation Use of green porphyrins to treat neovasculature in the eye
JP2961074B2 (ja) 1995-09-06 1999-10-12 明治製菓株式会社 光化学療法用の新生血管閉塞剤
WO1997016966A1 (en) * 1995-11-06 1997-05-15 New York Blood Center, Inc. Viral inactivation treatment of red blood cells using phthalocyanines and red light
JP3845469B2 (ja) 1996-02-21 2006-11-15 明治製菓株式会社 眼底の新生血管の閉塞に用いる投与剤
GB9700396D0 (en) * 1997-01-10 1997-02-26 Photocure As Photochemotherapeutic compositions
US6008889A (en) * 1997-04-16 1999-12-28 Zeng; Haishan Spectrometer system for diagnosis of skin disease
US6010890A (en) * 1997-04-29 2000-01-04 New York Blood Center, Inc. Method for viral inactivation and compositions for use in same
US6103706A (en) * 1997-04-29 2000-08-15 New York Blood Center, Inc. Methods for treating viral infections
DE19721489A1 (de) * 1997-05-23 1998-11-26 Tibor Dr Nagypal System zur photodynamischen Behandlung von Lebewesen, deren Organen und/oder Geweben
US6128525A (en) * 1997-07-29 2000-10-03 Zeng; Haishan Apparatus and method to monitor photodynamic therapy (PDT)
US6096066A (en) * 1998-09-11 2000-08-01 Light Sciences Limited Partnership Conformal patch for administering light therapy to subcutaneous tumors
US6117862A (en) * 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
US6602274B1 (en) * 1999-01-15 2003-08-05 Light Sciences Corporation Targeted transcutaneous cancer therapy
WO2000041725A2 (en) * 1999-01-15 2000-07-20 Light Sciences Corporation Therapeutic compositions for metabolic bone disorders or bone metastases
US6454789B1 (en) * 1999-01-15 2002-09-24 Light Science Corporation Patient portable device for photodynamic therapy
JP2002534218A (ja) * 1999-01-15 2002-10-15 ライト サイエンシーズ コーポレイション 非侵襲性の脈管療法
US20020022032A1 (en) * 1999-04-23 2002-02-21 Curry Patrick Mark Immuno-adjuvant PDT treatment of metastatic tumors
US20030114434A1 (en) * 1999-08-31 2003-06-19 James Chen Extended duration light activated cancer therapy
US7125897B1 (en) * 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
US7897140B2 (en) 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
CA2395567A1 (en) * 2000-01-12 2001-07-19 Light Sciences Corporation Novel treatment for eye disease
AU2001250401B2 (en) * 2000-03-24 2005-08-11 Novartis Ag Improved treatment of neovascularization
US6454790B1 (en) * 2000-07-21 2002-09-24 Ceramoptec Industries, Inc. Treatment for Barrett's syndrome
US7193706B2 (en) * 2000-08-02 2007-03-20 Arizona Board Of Regents, Acting On Behalf Of Arizona State University Computer interfaced scanning fluorescence lifetime microscope applied to directed evolution
WO2003047592A1 (en) * 2001-12-03 2003-06-12 The Regents Of The University Of California Photodynamic therapy for the treatment of epilepsy
DE10162712A1 (de) * 2001-12-19 2003-07-17 Blutspendienst Der Landesverba Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten
US20030167033A1 (en) * 2002-01-23 2003-09-04 James Chen Systems and methods for photodynamic therapy
US7041121B1 (en) * 2002-01-31 2006-05-09 Medtronicvidamed, Inc. Apparatus for treating prostate cancer and method for same
AU2003248747A1 (en) 2002-06-27 2004-01-19 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
EP1549268A2 (de) * 2002-10-03 2005-07-06 Light Sciences Corporation Anregung von photoreaktiven verbindungen im augengewebe
US7780992B2 (en) * 2002-12-08 2010-08-24 Tareq Abduljalil Albahri Antiviral medicament
US20040220167A1 (en) * 2003-05-02 2004-11-04 Nasrollah Samiy Methods of treating neuralgic pain
US20060020033A1 (en) * 2004-07-21 2006-01-26 Ali Moiin Method for treating dermatological viral infections
US20070299431A1 (en) * 2006-05-02 2007-12-27 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) * 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
KR101200210B1 (ko) * 2009-11-10 2012-11-09 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
WO2011059216A2 (ko) * 2009-11-10 2011-05-19 가톨릭대학교 산학협력단 광감작제가 코팅된 의료용 스텐트 및 이의 제조방법
US9211214B2 (en) 2012-03-21 2015-12-15 Valeant Pharmaceuticals International, Inc Photodynamic therapy laser
GB2517707B (en) 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
CN106620893B (zh) 2015-07-23 2021-07-30 爱博诺德(北京)医疗科技股份有限公司 用于眼部疾病光治疗的材料

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521762A (en) 1981-08-27 1985-06-04 Gte Automatic Electric Laboratories, Incorporated Integratable D/A converter
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4577636A (en) 1982-11-23 1986-03-25 The Beth Israel Hospital Association Method for diagnosis of atherosclerosis
ATE35834T1 (de) 1983-03-07 1988-08-15 Carcedo Jacinto Munoz Verankerungssysteme fuer trennwaende.
US4753958A (en) 1985-02-07 1988-06-28 University Of Cal Photochemotherapy of epithelial diseases with derivatives of hematoporphyrins
US5095030A (en) 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
DE68929063T2 (de) 1988-02-01 2000-02-24 Matsushita Electric Ind Co Ltd Dreidimensionale bildformungsanordnung
GB8805849D0 (en) * 1988-03-11 1988-04-13 Efamol Holdings Porphyrins & cancer treatment
US4925736A (en) 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
US5028594A (en) * 1988-12-27 1991-07-02 Naxcor Use of photodynamic compositions for cytotoxic effects
US4935498A (en) 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
CA2012175A1 (en) * 1989-03-31 1990-09-30 Michael W. Berns Photochemical treatment of blood vessels
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
CH684166A5 (it) * 1990-09-28 1994-07-29 Teclas Tecnologie Laser S A Apparecchiatura dedicata a radiazione rossa per fotochemioterapia.
PT660712E (pt) * 1992-09-21 2001-11-30 Quadra Logic Tech Inc Activacao in vivo transdermal de agentes fotossensiveis no sangue

Also Published As

Publication number Publication date
ATE322932T1 (de) 2006-04-15
ATE189966T1 (de) 2000-03-15
DE69327972D1 (de) 2000-04-06
CA2149636A1 (en) 1994-06-09
PL309033A1 (en) 1995-09-18
DE69327972T2 (de) 2000-11-02
FI952436A (fi) 1995-07-05
AU5460094A (en) 1994-06-22
EP0680365A1 (de) 1995-11-08
ZA938710B (en) 1994-06-30
HU224722B1 (en) 2006-01-30
US5770619A (en) 1998-06-23
ES2148132T1 (es) 2000-10-16
NO952004L (no) 1995-07-11
AU679016B2 (en) 1997-06-19
DE69334009T2 (de) 2006-11-23
KR100230588B1 (ko) 1999-12-01
JP3146008B2 (ja) 2001-03-12
HUT72037A (en) 1996-03-28
FI952436A0 (fi) 1995-05-19
PT680365E (pt) 2000-07-31
DK0680365T3 (da) 2000-06-05
WO1994012239A1 (en) 1994-06-09
PT947222E (pt) 2006-09-29
DE69334009D1 (de) 2006-05-24
IL107676A0 (en) 1994-02-27
NO323107B1 (no) 2007-01-02
PH31688A (en) 1999-01-18
EP0680365B1 (de) 2000-03-01
US5705518A (en) 1998-01-06
EP0947222B1 (de) 2006-04-12
EP0947222A2 (de) 1999-10-06
KR950704007A (ko) 1995-11-17
JPH08505069A (ja) 1996-06-04
HU9501489D0 (en) 1995-07-28
IL107676A (en) 1999-11-30
EP0947222A3 (de) 1999-10-27
PL172480B1 (pl) 1997-09-30
DK0947222T3 (da) 2006-09-04
ES2148132T3 (es) 2006-12-01
HK1025059A1 (en) 2000-11-03
CA2149636C (en) 2001-04-03
NO952004D0 (no) 1995-05-19
GR3033362T3 (en) 2000-09-29
ES2143539T3 (es) 2000-05-16

Similar Documents

Publication Publication Date Title
DE947222T1 (de) Verfahren zur Aktivierung von photoempfindlichen Mitteln
DE69523350D1 (de) Behandlung von hyperproliferativen Gefässerkrankungen
DK77090A (da) Immunmodulerende azaspiraner
LU90710I2 (fr) Galanthamine ou ses sels d'addition acides
DE69201128T2 (de) Behandlung von neoplastischen krankenheiten mit interleukin-10.
KR890700026A (ko) 건선 치료에 있어서 주석 프로토포르피린 및 주석 메조포르피린의 용도
DE69634981D1 (de) Verfahren zur festsetzung der optimalen strahlungsdosis zur strahlentherapie von krankheiten
ES8201535A1 (es) Un procedimiento para la preparacion de nuevos acil-deriva- dos de carnitina
MY104521A (en) Treatment of depression.
DE68910010D1 (de) Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
RU97101420A (ru) Способ лечения тонзиллита
SU1174042A1 (ru) Способ лечени неинфекционных заболеваний печени,осложненных желтухой
UA10928C2 (uk) Спосіб профілактики гіперхолестериhемії
ATE91236T1 (de) Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
RU96122371A (ru) Способ лечения эндогенных и послеоперационных увеитов
RU93040378A (ru) Способ воздействия на точки рефлекторно-пунктурной терапии
SU1797195A1 (ru) Способ профилактики радиационных поражений